Annual Statement of Changes in Beneficial Ownership (5)
16 February 2022 - 8:42AM
Edgar (US Regulatory)
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ]
Form 3 Holdings Reported
[ ]
Form 4 Transactions Reported
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0362
Estimated average burden hours per response...
1.0
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
ARONSTEIN MICHAEL | 2. Issuer Name and Ticker or Trading SymbolAngioGenex, Inc. [AGGX] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) __X__ Other (specify below) CHAIRMAN |
(Last)
(First)
(Middle)
425 MADISON AVE., SUITE 902 | 3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2021 |
(Street)
NEW YORK, NY 10017
(City)
(State)
(Zip)
| 4. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any | 3. Trans. Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) |
Amount | (A) or (D) | Price |
Common Stock | 10/23/2019 | | A | 250000 | A | $25000 | 6000000 | D | |
Common Stock | 12/30/2019 | | A | 250000 | A | $25000 | 6000000 | D | |
Common Stock | 3/3/2020 | | A | 25000 | A | $5000 | 6130555 | D | |
Common Stock | 8/5/2020 | | A | 50000 | A | $10000 | 6130555 | D | |
Common Stock | 10/8/2020 | | A | 55555 | A | $10000 | 6130555 | D | |
Common Stock | 3/2/2021 | | A | 400000 | A | $100000 | 7507827 | D | |
Common Stock | 6/8/2021 | | A | 227272 | A | $25000 | 7507827 | D | |
Common Stock | 8/31/2021 | | A | 750000 | A | $100000 | 7507827 | D | |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (MM/DD/YYYY) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
(A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option | $0.35 | 1/15/2019 | | A | 3000000 | | 1/15/2020 | 1/15/2024 | Common Stock | 3000000 | $.035 | 3000000 | D | |
Stock Option | $.13 | 9/2/2021 | | A | 2000000 | | 9/2/2021 | 9/2/2026 | Common Stock | 2000000 | $.13 | 5000000 | D | |
Convertible Note | $25 | 11/2/2021 | | A | 240000 | | 11/2/2021 | 10/31/2023 | Common Stock | 240000 | $.25 | 5240000 | D | |
Explanation of Responses: |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
ARONSTEIN MICHAEL 425 MADISON AVE. SUITE 902 NEW YORK, NY 10017 | X | X |
| CHAIRMAN |
Signatures
|
/s/ MICHAEL ARONSTEIN | | 2/15/2022 |
**Signature of Reporting Person | Date |
AngioGenex (CE) (USOTC:AGGX)
Historical Stock Chart
From Apr 2024 to May 2024
AngioGenex (CE) (USOTC:AGGX)
Historical Stock Chart
From May 2023 to May 2024